Over the past 10 years, the EIP open symposium became the yearly rendez-vous of industry players, regulators and scientist in the field of immunogenicity.
In 3 days, you will enjoy a broad spectrum of presentations and plenty of networking opportunities.
For the 2017 edition, we have teamed up with the ABIRISK project team, to cover an ever wider field of the immunogenicity research and its clinical effects.
Therefore, we have moved to a larger facility and now can accept a maximum of 250 registrations.
Organized under the flag of ABIRISK and the European Immunogenicity Platform (EIP), a central meeting place for European biopharmaceutical companies and scientific experts active in the field of immunogenicity.